It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Histone modifications are associated with distinct transcriptional states, but it is unclear whether they instruct gene expression. To investigate this, we mutate histone H3.3 K9 and K27 residues in mouse embryonic stem cells (mESCs). Here, we find that H3.3K9 is essential for controlling specific distal intergenic regions and for proper H3K27me3 deposition at promoters. The H3.3K9A mutation resulted in decreased H3K9me3 at regions encompassing endogenous retroviruses and induced a gain of H3K27ac and nascent transcription. These changes in the chromatin environment unleash cryptic enhancers, resulting in the activation of distinctive transcriptional programs and culminating in protein expression normally restricted to specialized immune cell types. The H3.3K27A mutant disrupts the deposition and spreading of the repressive H3K27me3 mark, particularly impacting bivalent genes with higher basal levels of H3.3 at promoters. Therefore, H3.3K9 and K27 crucially orchestrate repressive chromatin states at cis-regulatory elements and bivalent promoters, respectively, and instruct proper transcription in mESCs.
In this study, the authors mutate histone H3.3 K9 and K27 residues, demonstrating their importance in maintaining repressive chromatin states at endogenous retrovirus-derived cryptic enhancers and bivalent promoters in mouse embryonic stem cells.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Bunina, Daria 2 ; Yildiz, Umut 1
; Fernandez-Novel Marx, Nadine 3 ; Uckelmann, Michael 4 ; Levina, Vita 4 ; Perez, Yekaterina 5
; Janeva, Ana 3 ; Garcia, Benjamin A. 5
; Davidovich, Chen 4
; Zaugg, Judith B. 6
; Noh, Kyung-Min 3
1 Genome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany (GRID:grid.4709.a) (ISNI:0000 0004 0495 846X); Faculty of Biosciences, Collaboration for joint PhD degree between EMBL and Heidelberg University, Heidelberg, Germany (GRID:grid.7700.0) (ISNI:0000 0001 2190 4373)
2 Genome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany (GRID:grid.4709.a) (ISNI:0000 0004 0495 846X); Structural and Computational Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany (GRID:grid.4709.a) (ISNI:0000 0004 0495 846X)
3 Genome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany (GRID:grid.4709.a) (ISNI:0000 0004 0495 846X)
4 and EMBL-Australia, Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857)
5 Washington University School of Medicine, Department of Biochemistry and Molecular Biophysics, St. Louis, USA (GRID:grid.4367.6) (ISNI:0000 0001 2355 7002)
6 Structural and Computational Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany (GRID:grid.4709.a) (ISNI:0000 0004 0495 846X)




